
|Videos|April 14, 2023
ADT as the Backbone for Combination Treatments in Advanced Prostate Cancer
A focused discussion on how ADT is used as the backbone of prostate cancer therapy across different prostate cancer risk groups and according to metastatic and castration sensitivity status.
Advertisement
January 2023 AbbVie Inc. Company Confidential
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Ravi Munver, MD, highlights study of first- and second-generation Aquablation systems
2
The UroOnc Minute: AUA 2026 Update on Prostate Cancer Early Detection, With Badrinath R. Konety, MBBS
3
EV plus pembro approval reframes first conversation in MIBC diagnosis
4
Genomic Prostate Score may help refine risk assessment in localized prostate cancer
5














